開發以尼古丁乙醯膽鹼受體為標靶應用於乳癌之新穎治療藥物

Biochemistry, Genetics and Molecular Biology

1. Nicotinic Acetylcholine Receptor 100%
2. Trastuzumab 100%
3. Antibodies 25%
4. Complex Formation 25%
5. Cancer Cell 25%
6. Energy Transfer 12%
7. RNA 12%
8. Drug Resistance 12%
9. Anticancer 12%
10. Nicotinic Receptor 12%
11. Animal Model 12%
12. Tumor Progression 12%
13. Binding Affinity 12%
14. Antibody Library 12%
15. Immune Response 12%
16. Cancer Staging 12%
17. Cancer Stem Cell 12%

Pharmacology, Toxicology and Pharmaceutical Science

1. Breast Cancer 100%
2. Nicotinic Receptor 100%
3. Trastuzumab 66%
4. Neoplasm 41%
5. Breast Tumor 33%
6. Antibodies 16%
7. Cancer Staging 8%
8. Acute Toxicity 8%
9. Drug Resistance 8%
10. Malignant Neoplasm 8%
11. Tumor Growth 8%
12. Cancer Growth 8%
13. Cancer Antibody 8%
14. Anticancer Drug 8%